NIOSH is offering this grant to continue and expand the National Mesothelioma Virtual Bank (NMVB) for Translational Research. Established in 2006, the NMVB is a vital resource for advancing biomedical understanding of malignant mesothelioma, its progression, and the development of new treatments, therapeutics, and diagnostics. This grant aims to expand the collection of biospecimens and related data. NIOSH’s continued support ensures uninterrupted assistance for mesothelioma researchers, preventing critical support gaps. This initiative also demonstrates a sustained public health commitment to improving treatment and affirming support for workers and other individuals impacted by this disease.
Opportunity ID: 331066
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-OH-21-007 |
| Funding Opportunity Title: | Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.262 — Occupational Safety and Health Program |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jan 22, 2021 |
| Last Updated Date: | Jan 25, 2021 |
| Original Closing Date for Applications: | Mar 02, 2021 Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information it contains allows CDC staff to plan the review. By the date listed above and in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:
Name of the Applicant The letter of intent should be sent to: |
| Current Closing Date for Applications: | Mar 25, 2021 Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information it contains allows CDC staff to plan the review. By the date listed above and in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:
Name of the Applicant The letter of intent should be sent to: |
| Archive Date: | – |
| Estimated Total Program Funding: | $5,500,000 |
| Award Ceiling: | $1,100,000 |
| Award Floor: | $800,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | This is a single-eligibility award. Only the University of Pittsburgh, the institution with the existing National Mesothelioma Virtual Bank for Translational Research, is eligible to apply. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The National Mesothelioma Virtual Bank for Translational Research (NMVB) was established in fiscal year 2006 to serve as an exceptional resource for mesothelioma research. RFA-OH-21-007 will continue the NMVB to advance biomedical research for malignant mesothelioma to gain a better understanding of the disease and its progression, and the potential development of new treatments, therapeutics, and diagnostics for mesothelioma. Continued support to the NMVB will allow expansion of collection of biospecimens, related data, and other information. NIOSH intends to continue the NMVB at the University of Pittsburgh to accomplish the following important program priorities: maintain uninterrupted assistance to mesothelioma researchers; avoid critical support gaps for current or pending mesothelioma research efforts; demonstrate a sustained public health commitment to advancing the treatment of mesothelioma; and affirm a sustained commitment to workers and other people impacted by this disease. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
BRIDGETTE GARRETT
beg8@cdc.gov Email:beg8@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Updated application due date | Jan 25, 2021 | |
| Jan 22, 2021 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-OH-21-007 |
| Funding Opportunity Title: | Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.262 — Occupational Safety and Health Program |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jan 22, 2021 |
| Last Updated Date: | Jan 25, 2021 |
| Original Closing Date for Applications: | Mar 02, 2021 Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information it contains allows CDC staff to plan the review. By the date listed above and in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:
Name of the Applicant The letter of intent should be sent to: |
| Current Closing Date for Applications: | Mar 25, 2021 Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information it contains allows CDC staff to plan the review. By the date listed above and in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:
Name of the Applicant The letter of intent should be sent to: |
| Archive Date: | – |
| Estimated Total Program Funding: | $5,500,000 |
| Award Ceiling: | $1,100,000 |
| Award Floor: | $800,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | This is a single-eligibility award. Only the University of Pittsburgh, the institution with the existing National Mesothelioma Virtual Bank for Translational Research, is eligible to apply. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The National Mesothelioma Virtual Bank for Translational Research (NMVB) was established in fiscal year 2006 to serve as an exceptional resource for mesothelioma research. RFA-OH-21-007 will continue the NMVB to advance biomedical research for malignant mesothelioma to gain a better understanding of the disease and its progression, and the potential development of new treatments, therapeutics, and diagnostics for mesothelioma. Continued support to the NMVB will allow expansion of collection of biospecimens, related data, and other information. NIOSH intends to continue the NMVB at the University of Pittsburgh to accomplish the following important program priorities: maintain uninterrupted assistance to mesothelioma researchers; avoid critical support gaps for current or pending mesothelioma research efforts; demonstrate a sustained public health commitment to advancing the treatment of mesothelioma; and affirm a sustained commitment to workers and other people impacted by this disease. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
BRIDGETTE GARRETT
beg8@cdc.gov Email:beg8@cdc.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-OH-21-007 |
| Funding Opportunity Title: | Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.262 — Occupational Safety and Health Program |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 22, 2021 |
| Last Updated Date: | Jan 22, 2021 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 02, 2021 Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information it contains allows CDC staff to plan the review. By the date listed above and in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:
Name of the Applicant The letter of intent should be sent to: |
| Archive Date: | – |
| Estimated Total Program Funding: | $5,500,000 |
| Award Ceiling: | $1,100,000 |
| Award Floor: | $800,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | This is a single-eligibility award. Only the University of Pittsburgh, the institution with the existing National Mesothelioma Virtual Bank for Translational Research, is eligible to apply. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The National Mesothelioma Virtual Bank for Translational Research (NMVB) was established in fiscal year 2006 to serve as an exceptional resource for mesothelioma research. RFA-OH-21-007 will continue the NMVB to advance biomedical research for malignant mesothelioma to gain a better understanding of the disease and its progression, and the potential development of new treatments, therapeutics, and diagnostics for mesothelioma. Continued support to the NMVB will allow expansion of collection of biospecimens, related data, and other information. NIOSH intends to continue the NMVB at the University of Pittsburgh to accomplish the following important program priorities: maintain uninterrupted assistance to mesothelioma researchers; avoid critical support gaps for current or pending mesothelioma research efforts; demonstrate a sustained public health commitment to advancing the treatment of mesothelioma; and affirm a sustained commitment to workers and other people impacted by this disease. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
BRIDGETTE GARRETT
beg8@cdc.gov Email:beg8@cdc.gov |
Related Documents
Folder 331066 Full Announcement-Full Announcement -> OH-21-007_Final NOFO_01.25.2021.pdf
Packages
| Agency Contact Information: | BRIDGETTE GARRETT beg8@cdc.gov Email: beg8@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.262 | RFA-OH-21-007 | Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24) | PKG00265131 | Jan 25, 2021 | Mar 25, 2021 | View |
Package 1
Mandatory forms
331066 RR_SF424_2_0-2.0.pdf
331066 PHS398_CoverPageSupplement_5_0-5.0.pdf
331066 PHS398_ResearchPlan_4_0-4.0.pdf
331066 RR_Budget_1_4-1.4.pdf
331066 RR_OtherProjectInfo_1_4-1.4.pdf
331066 PerformanceSite_2_0-2.0.pdf
331066 RR_KeyPersonExpanded_2_0-2.0.pdf
331066 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
331066 PHS_AssignmentRequestForm_3_0-3.0.pdf
331066 RR_SubawardBudget30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
